Cardiovascular Renal Metabolic

Liver Stiffness to Assess Central Venous Pressure in HF

Nicolas Girerd

Watch time: 2m 40s
Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
ESC HF 25: The FIVE-STAR Trial

Watch time: 2m 40s
ESCHFA25: FINEARTS-HF: Finerenone Risk-Benefit Across Kidney Function

Safia Chatur

Watch time: 5m 49s
ESC HF 25: The PRAISE-HFrEF Study

Varun Sundaram

Watch time: 4m 10s

Martin Berger , Nikolaus Marx , Katharina Marx-Schütt

Read time: 16m 8s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s
THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s

David Wheeler, Carol Pollock et al

Muthiah Vaduganathan

Sydney Tang et al

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Lee Kaplan, Fatima Cody Stanford, Filip Knop, et al

Andrew JS Coats, Stefan Anker

Watch time: 8m 53s (5 videos)

Neha Pagidipati, Linda Mellbin et al

Watch time: 2h (19 videos)

David K Ryan , Debasish Banerjee , Fadi Jouhra

Read time: 10m

Shelley Zieroth et al

Watch time: 20m 16s (3 videos)

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Media

Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
ESC HF 25: The FIVE-STAR Trial

Watch time: 2m 40s
Liver Stiffness to Assess Central Venous Pressure in HF

Nicolas Girerd

Watch time: 2m 40s
ESCHFA25: FINEARTS-HF: Finerenone Risk-Benefit Across Kidney Function

Safia Chatur

Watch time: 5m 49s
ESC HF 25: The PRAISE-HFrEF Study

Varun Sundaram

Watch time: 4m 10s

Yassir Javaid et al

Watch time: 18m 47s (4 videos)
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s
ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi

Watch time: 23m 6s

Su Down, Jas Gill, Andrew Frankel, et al

Watch time: 56m 1s (5 videos)

Articles

Cardiovascular Disease and Type 2 Diabetes

Martin Berger

,

Nikolaus Marx

,

Katharina Marx-Schütt

,

Published:

15 April 2025

Citation:

European Cardiology Review 2025;20:e09.

DOI:

https://doi.org/10.15420/ecr.2024.29
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 439
  • Downloads: Downloads 45
  • Read time: 16m 8s

Maternal Cardiac Function in Pregnancies With Metabolic Disorders

Deesha Patel

,

Makrina D Savvidou

,

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e08.

DOI:

https://doi.org/10.15420/ecr.2023.28
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 570
  • Downloads: Downloads 21
  • Read time: 22m 59s

Treatment Options and Continuity of Care in MAFLD

Carmen Lara-Romero

,

Manuel Romero-Gómez

,

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e06.

DOI:

https://doi.org/10.15420/ecr.2023.34
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1896
  • Downloads: Downloads 46
  • Citations: 6
  • Read time: 20m 32s

Link Between NAFLD/NASH and Cardiometabolic Syndrome

Sheila Gato

,

Vanessa García-Fernández

,

Antonio Gil-Gómez

,

Ángela Rojas

,

Rocío Montero-Vallejo

,

Rocío Muñoz-Hernández

,

Manuel Romero-Gómez

,

Published:

09 May 2024

Citation:

European Cardiology Review 2024;19:e03.

DOI:

https://doi.org/10.15420/ecr.2023.26
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 901
  • Downloads: Downloads 49
  • Citations: 3
  • Read time: 20m 25s